Trial intelligence / Profile preview

Bupivacaine Caudal Block Volumes in Pediatric Surgery

NCT05133687Phase 3Completed

Sponsor
Kasr Al Ainy Hospital
Start
Nov 2021
Primary completion
May 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of bupivacaine, sponsored by Kasr Al Ainy Hospital. Started Nov 2021; status: completed.

02

Drugs

bupivacaine

Beyond the preview

Go deeper on NCT05133687.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05133687.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call